Benzenod 3 mg (Capsule)
Unit Price: ৳ 40.00 (2 x 14: ৳ 1,120.00)
Strip Price: ৳ 560.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Rivastigmine tartrate |
| Company | General pharmaceuticals ltd |
| Also available as |
Title
- Benzenod Capsule
- Rivastigmine Transdermal Patch
Categories
- Alzheimer's Disease Medication
- Parkinson's Disease Medication
- Dementia Treatment
Description
- Symptomatic treatment of Alzheimer's dementia and Parkinson's disease dementia
- Cholinesterase inhibitor with pharmacological activity
- Dosage guidance and administration instructions
- Possible drug interactions and contraindications
- Known side effects and overdose effects
- Special populations and storage conditions
Color Options
Dosage Form
- Capsule
- Transdermal Patch
Dosage Strength
- 1.5 mg
- 3 mg
- 4.6 mg/24 hours
- 9.5 mg/24 hours
- 13.3 mg/24 hours
Dose Titration Information
- Gradual increase based on tolerability and efficacy
- Initial dose titration
- Maximum daily dose recommendation
- Retitration after treatment interruption
Administration Frequency
- Twice a day with meals for capsules
- Once a day for transdermal patch
Pharmacological Class
- Cholinesterase Inhibitor
- Carbamate Derivative
Mechanism of Action
- Reversible inactivation of cholinesterase enzymes
- Increased concentration of acetylcholine at synapses
Interaction with Other Medications
- Exaggeration of succinylcholine-type muscle relaxants
- Caution with anaesthetic agents
- Potential interference with cholinomimetic substances and anticholinergic medicinal products
- No observed pharmacokinetic interactions with specific medications
Contraindications
- Hypersensitivity to the active substance or other carbamate derivatives
Common Side Effects
- Gastrointestinal reactions (e.g., nausea, vomiting)
- Possible weight loss
- Gender-specific susceptibility in clinical studies
Pregnancy & Lactation Precautions
- Limited clinical data available
- Avoid use during pregnancy unless clearly necessary
- Potential excretion into breast milk
Precautions & Warnings
- Patients with specific cardiac and respiratory conditions
- Exacerbation potential for urinary obstruction, seizures, gastric acid secretion, and extrapyramidal symptoms
- Monitoring of body weight and consideration of renal/hepatic impairment
Use in Special Populations
- Increased exposure in moderate renal and mild to moderate hepatic impairment
- Not recommended for use in children
Storage Conditions
- Cool, dry place
- Protected from light
Therapeutic Class
- Drugs for Dementia
Overdose Effects
- Clinical signs and symptoms associated with accidental overdose
- Vagotonic effect on heart rate
- Symptomatic treatment recommendations
- Asymptomatic overdose management
Pediatric Uses
- Not recommended for use in children
Renal and Hepatic Impairment
- Dosing recommendations based on individual tolerability
Drug Classes
- Dementia Treatments